Figure 1.
![Comparison of overall survival and posttransplant survival of patients with primary myelofibrosis (PMF) stratified by race (Black African American vs non-African-American∗). ∗95% Caucasian. (A) Overall survival of 1354 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]). (B) Posttransplant survival of 76 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]).](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/12/10.1182_bloodadvances.2022009611/2/blooda_adv-2022-009611-gr1.jpeg?Expires=1735795238&Signature=uTWZHdUmsNKVWUrLfrewBhk36O4gynugeUN1858VzKoZBVa-Rp0PiTOFPlu46dsjy3Cat0qpeFKx0vW82Eb8ezmqvGzLIz7Mc9hhwRjNvPhwzlF21GcG3B1PMR2ksIf6KLLlByFTAs1qpmxz6t1IiLP-q1bJRbQBY4-bMvdg2w0cfQOjeABAzrJrlG8fD~u37vQLHT27i2mtKzW~luTTQLITusLKpX1-YU-u3mh92NPvrwpri5zWxS0yI3V1MNQbhM6U69hP2hXFcgu1H0XyGF~h1HI4oNB0nzYbaQreNsOFwdYJ7VCPExxw1NYBuaw6Mho~kNNJNNYyi16I9vEP4Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparison of overall survival and posttransplant survival of patients with primary myelofibrosis (PMF) stratified by race (Black African American vs non-African-American∗). ∗95% Caucasian. (A) Overall survival of 1354 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]). (B) Posttransplant survival of 76 patients with PMF stratified based on race (Black AA vs non-AA [95% Caucasian]).
